Bacil Pharma Limited Stock

Equities

BACPHAR6

INE711D01018

Market Closed - Bombay S.E. 06:00:50 2024-05-14 EDT 5-day change 1st Jan Change
23.25 INR -1.98% Intraday chart for Bacil Pharma Limited -0.04% +264.42%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site

Financials

Sales 2022 - Sales 2023 - Capitalization 32.28M 2.69B 44.03M
Net income 2022 -38M -3.17B -51.84M Net income 2023 -1M -83.46M -1.36M EV / Sales 2022 -
Net cash position 2022 4.59M 383M 6.26M Net cash position 2023 1.99M 166M 2.72M EV / Sales 2023 -
P/E ratio 2022
-0.87 x
P/E ratio 2023
-32.2 x
Employees 2
Yield 2022 *
-
Yield 2023
-
Free-Float 0%
More Fundamentals * Assessed data
Dynamic Chart
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023 CI
Bacil Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September 30, 2023 CI
Bacil Pharma Limited Appoints Mrs. Bhavana Tak as Company Secretary and Compliance Officer CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2023 CI
Bacil Pharma Narrows Net Loss in Fiscal Q4 MT
Bacil Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2023 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2023 CI
Bacil Pharma Limited Announces Resignation of Vaishali Vaghasiya, Company Secretary & Compliance , Effective 1 April,2023 CI
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2022 CI
Bacil Pharma Limited Appoints Suman Shah as Non-Executive Non- Independent Director CI
Bacil Pharma Limited Reports Earnings Results for the First Quarter Ended June 30, 2022 CI
Bacil Pharma Limited Reports Earnings Results for the Full Year Ended March 31, 2022 CI
Bacil Pharma Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2022 CI
Bacil Pharma Gets Board Approval to Foray into Agricultural Business MT
Bacil Pharma Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2021 CI
More news
1 day-1.98%
1 week-0.04%
Current month+8.09%
1 month+33.31%
3 months+185.63%
6 months+207.95%
Current year+264.42%
More quotes
1 week
23.25
Extreme 23.25
24.66
1 month
18.13
Extreme 18.13
24.66
Current year
6.63
Extreme 6.63
24.66
1 year
4.68
Extreme 4.68
24.66
3 years
3.67
Extreme 3.67
24.66
5 years
1.57
Extreme 1.57
24.66
10 years
1.57
Extreme 1.57
24.66
More quotes
Managers TitleAgeSince
Director of Finance/CFO - 15-03-30
Compliance Officer - 23-09-13
Director/Board Member 69 02-06-09
Members of the board TitleAgeSince
Director/Board Member 69 03-03-24
Director/Board Member 68 90-08-08
Director/Board Member 69 02-06-09
More insiders
Date Price Change Volume
24-05-14 23.25 -1.98% 191
24-05-13 23.72 -1.98% 545
24-05-10 24.2 +0.04% 1,641
24-05-09 24.19 +1.98% 100
24-05-08 23.72 +1.98% 2,054

Delayed Quote Bombay S.E., May 14, 2024 at 06:00 am

More quotes
  1. Stock Market
  2. Equities
  3. BACPHAR6 Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW